When the covid-19 pandemic hit, Dr. Corey Siegel was more prepared than most of his peers.

Eating more ultraprocessed foods raises the risk of developing and dying from cancer, especially ovarian cancer, according to a new study of over 197,000 people in the United Kingdom, over half of whom were women.

Colleen Moretti: Where have we seen the most of the advancements or improvements in oncology care over the years? Dr. Miriam Atkins: That's a great question and I can certainly answer that because I've been doing oncology since 1993 — so almost 30 years so I've seen a lot of changes, and it's makes me very happy.

The World Health Organization (WHO) said on Monday that COVID-19 continues to constitute a public health emergency of international concern, its highest form of alert.

Giving chemotherapy in the morning resulted in worse survival and worse toxicity in comparison with giving the same drugs in the afternoon, say researchers.

Fatigue and poor physical functioning before starting treatment for early breast cancer were independently associated with chemotherapy dose reductions and post-chemotherapy toxicities, a new analysis found.

Colleen Moretti: What are some common challenges that we're seeing in clinical trials right now? Dr. Miriam Atkins: The most common challenge I would believe are some patients feel like they're being experimented on with clinical trials.

Cancer is a disease that harms our physical well-being and deeply impacts our identity, daily life, and loved ones. Despite the devastation it causes, we are currently experiencing a breakthrough in cancer treatment.

Body composition may play a role in the survival outcomes of men with localized prostate cancer, according to a study that was recently published in the journal, Cancer.